The Osseotite Implant features the proprietary Zimmer Biomet dual-acid-etched surface that is designed for improving the clot/implant attachment, which may increase platelet activation and red blood cell (rbc) agglomeration.1 For more than 15 years with documentation from numerous global multicenter clinical evaluations,2-9 the Osseotite Surface has proven to be one of the most predictable and well-researched surfaces. Clinical studies on the Osseotite Surface document the benefits of increased